Adoption of Income Statement and Balance Sheet for the Financial Year 2024 and Discharge from Liability
The AGM adopted the income statements and balance sheets for the Company and the Group for 2024. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2024.

Allocation of Profits
The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for 2024 and that the Company’s available earnings shall be carried forward.

Election of Board Members, Auditors, Fees to the Board of Directors and Auditors
The AGM resolved, in accordance with the Nomination Committee’s proposal, that the number of members of the Board of Directors shall be seven without deputies and that the number of auditors shall be one registered accounting firm.

In accordance with the Nomination Committee’s proposal, the AGM re-elected the Board members Anders Jöfelt, Lars Olofsson, Mats Krantz, Cecilia Wachtmeister and Magnus Jonsson and elected Maria Hedengren and Andreas Anyuru as new members of the Board of Directors. All elections for the period until the end of the next Annual General Meeting. Anders Jöfelt was re-elected as the Chairman of the Board of Directors. The registered audit firm Öhrlings PricewaterhouseCoopers AB was elected as auditor of the Company, and it was noted that Johan Malmqvist will be auditor-in-charge, for the period until the end of the next Annual General Meeting.

The AGM further resolved, in accordance with the Nomination Committee’s proposal and for the period until the end of the next Annual General Meeting, that remuneration to the Board of Directors shall be paid with SEK 700,000 to the Chairman of the Board of Directors, SEK 450,000 to the Deputy Chairman of the Board of Directors and SEK 310,000 to each of the other members of the Board of Directors. Remuneration is not paid to Board members employed by the group. Further, remuneration shall be paid with SEK 155,000 to the Chairman of the Audit Committee, SEK 65,000 to each of the other members of the Audit Committee, SEK 63,000 to the Chairman of the Remuneration Committee and SEK 42,000 to the other member of the Remuneration Committee. The AGM further resolved that the remuneration to the auditor shall be paid in accordance with approved statement of costs.

Determination of principles for the appointment of the members of the Nomination Committee
The AGM resolved, in accordance with the Nomination Committee’s proposal, that the principles for the appointment of the members of the Nomination Committee shall remain unchanged.

Adoption of a long-term incentive programme
The AGM resolved, in accordance with the Board of Directors’ proposal, to adopt a long-term incentive programme in the form of performance-based share options (Share Option Programme 2025) directed to employees within the Smart Eye group. The rationale behind the incentive programme is, among other things, to contribute to higher motivation and commitment among the employees, as well as strengthening the ties between the employees and the Company.

The Share Option Programme 2025 is proposed to comprise of the CEO, senior executives, key individuals and other employees, meaning that not more than approximately 200 employees within the Smart Eye group will be able to participate. Under the Share Option Programme 2025, participants are given the opportunity to receive shares free of charge, so called performance shares, provided that certain conditions are met and that one of the three performance goals specified in the program is achieved in whole or in part. Vesting of rights occurs during the period from July 15, 2025, to July 15, 2028.

The maximum number of performance shares will amount to 652,000, whereby 547,000 shares shall be allotted to participants and 105,000 shares shall be used by the Company to cover social security contributions associated with the programme. In order to enable the incentive programme, the AGM also resolved on an issue of not more than 652,000 warrants directed to the Company, as a result of which the Company’s share capital may increase by a maximum of SEK 65,200.

Resolution to carry out a directed issue of warrants to Smart Eye and approval of subsequent transfer of warrants
The AGM resolved, in accordance with the Board of Directors’ proposal, on a directed issue of warrants to the Company totalling 1,770,800 warrants. As a result of the issue, the Company's share capital may increase by a maximum of SEK 177,080. The rationale for the deviation from the shareholders’ pre-emption rights is to align the legal and administrative procedure for execution of the Share Option Programmes adopted in 2022, 2023 and 2024 respectively, with the procedure established for the proposed Share Option Programme 2025. The resolution will result in previous issues of warrants resolved to facilitate the Share Option Programs 2022, 2023, and 2024 losing their purpose and shall not be exercised. Thus, the previous aggregated dilution pursuant to the already issued warrants will remain unchanged.

Authorisation for the Board of Directors to resolve on new share issues
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board of Directors, on one or several occasions and with or without deviation from the shareholders’ preferential rights, to resolve on new share issues. The authorisation may be utilised for new issues of shares, which may be made with provisions regarding contribution in cash, in kind or through set-off corresponding to not more than 10 per cent of the registered share capital in the Company at the time of the issue resolution. The subscription price shall be determined on market terms and conditions. However, in order to enable delivery of shares in connection with a cash issue as described above, this may, if the Board of Directors deems it appropriate, be made at a subscription price corresponding to the quota value of the shares, whereby the issue is directed to an issuing agent that acts as a settlement bank for investors. Deviation from the shareholders’ preferential rights shall be possible in connection with future investments in the form of acquisitions of operations, companies, shares in companies or otherwise for the Company’s continued expansion. If the Board of Directors resolves on an issue with deviation from the shareholders’ preferential rights, the rationale shall be that the Board of Directors shall be able to issue shares in the Company to be used as a means of in-kind payment or the right to offset debt or to in a flexible and cost-efficient manner raise capital to use as means of payment or to continuously adjust the Company’s capital structure.